Login
Toggle sidebar

Lint: fluorine-18-labeled-sodium-fluoride

Isotope Notation
error

"Fluorine-18-labelled sodium fluoride (also known as 18F-NaF or sodium fluoride) is a PET radiotracer used primarily for skeletal imaging."

Line 1:86 · Write the isotope as symbol-mass, e.g. F-18, not '18F'.

"The primary clinical use of sodium fluoride PET is in detection of osseous prostate cancer metastasis. It is FDA-approved for PET imaging in evaluation of metastatic bone disease and for evaluation of treatment response 2. However, its use has been largely replaced by 18F and 68Ga PSMA PET imaging, which offer superior sensitivity, particularly in patients with low PSA levels."

Line 9:303 · Write the isotope as symbol-mass, e.g. F-18, not '18F'.

"The primary clinical use of sodium fluoride PET is in detection of osseous prostate cancer metastasis. It is FDA-approved for PET imaging in evaluation of metastatic bone disease and for evaluation of treatment response 2. However, its use has been largely replaced by 18F and 68Ga PSMA PET imaging, which offer superior sensitivity, particularly in patients with low PSA levels."

Line 9:322 · Write the isotope as symbol-mass, e.g. F-18, not '68Ga'.
Hybrid Imaging Slash
error

"Sodium fluoride PET has higher sensitivity and specificity in detecting and diagnosing bone diseases compared with conventional bone scintigraphy, even when the latter is supplemented with SPECT or SPECT/CT imaging 2."

Line 8:202 · Hybrid imaging takes a hyphen, not a slash: 'SPECT/CT'.
Acronyms
warning

"The primary clinical use of sodium fluoride PET is in detection of osseous prostate cancer metastasis. It is FDA-approved for PET imaging in evaluation of metastatic bone disease and for evaluation of treatment response 2. However, its use has been largely replaced by 18F and 68Ga PSMA PET imaging, which offer superior sensitivity, particularly in patients with low PSA levels."

Line 9:120 · 'FDA' has no definition. Spell it out if it's unfamiliar to the audience.

"The primary clinical use of sodium fluoride PET is in detection of osseous prostate cancer metastasis. It is FDA-approved for PET imaging in evaluation of metastatic bone disease and for evaluation of treatment response 2. However, its use has been largely replaced by 18F and 68Ga PSMA PET imaging, which offer superior sensitivity, particularly in patients with low PSA levels."

Line 9:336 · 'PSMA' has no definition. Spell it out if it's unfamiliar to the audience.

"The primary clinical use of sodium fluoride PET is in detection of osseous prostate cancer metastasis. It is FDA-approved for PET imaging in evaluation of metastatic bone disease and for evaluation of treatment response 2. However, its use has been largely replaced by 18F and 68Ga PSMA PET imaging, which offer superior sensitivity, particularly in patients with low PSA levels."

Line 9:426 · 'PSA' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Structure"

Line 2:1 · "Structure" is not a recognised heading for this article type.

"Distribution"

Line 4:1 · "Distribution" is not a recognised heading for this article type.

"Clinical uses"

Line 7:1 · "Clinical uses" is not a recognised heading for this article type.